NumFin

Evolent Health, Inc.

符号: EVH

NYSE

31.93

USD

今天的市场价格

  • -27.2314

    市盈率

  • 0.0238

    PEG比率

  • 3.69B

    MRK市值

  • 0.00%

    DIV收益率

Evolent Health, Inc. (EVH) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Evolent Health, Inc. (EVH). 的默认数据。公司收入显示 628.315 M 的平均值，即 0.403 % 增长率。整个期间的平均毛利润为 189.825 M，即 0.314 %. 平均毛利率为 0.216 %. 公司去年的净收入增长率为 5.045 %，等于 0.352 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Evolent Health, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 0.475. 在流动资产领域，EVH 的报告货币为683.673. 这些资产中的很大一部分，即 192.825 是现金和短期投资。与去年的数据相比，该部分的变化率为0.025%. 公司的长期投资虽然不是其重点，但以报告货币计算的4.895（如果有的话）为4.895。这表明与上一报告期相比，9.385% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 635.058. 这一数字表明，0.354% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 1067.701. 这方面的年同比变化率为 0.242%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为446.749，存货估值为 0，商誉估值为 1116.54（如有. 无形资产总额（如果有）按 752.01 估值. 应付账款和短期债务分别为 48.25 和 9.74. 债务总额为644.8，债务净额为 451.97. 其他流动负债为 610.28，加上总负债 1612.61. 最后，如果存在推荐股票，则其估值为 178.43.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

677.41192.8188.2266.3
340.5
101
228.3
238.4
178.9
155.2
0
67.9
5.3

balance-sheet.row.short-term-investments

118.913.814.575.7
3.9
1.8
0.8
62.4
44.3
9.4
0
0
0

balance-sheet.row.net-receivables

1480.17446.7254.7130.6
126.3
77.4
82.3
68.9
40.6
20.4
0
10.5
2.1

balance-sheet.row.inventory

-816.510-415.9-308.2
-445.1
-150.1
78.5
-3.3
-40.6
-20.4
0
0
0

balance-sheet.row.other-current-assets

1020.330.3451.1435.3
524.4
200.5
98.8
74.1
86.1
29.3
1.1
1.9
0.4

balance-sheet.row.total-current-assets

2375.14683.7478.1524
546.1
228.8
488
378.2
265
184.5
1.1
80.3
7.8

balance-sheet.row.property-plant-equipment-net

431.590.2136.9131.6
144
157.3
73.6
50.9
31.2
12.8
0
14.3
3.8

balance-sheet.row.goodwill

4469.591116.5722.8426.3
354.7
572.1
768.1
628.2
626.6
608.9
0
0
0

balance-sheet.row.intangible-assets

3157.46752442.8279.8
268.1
308.5
335
241.3
258.9
163.2
0.6
1.6
2.2

balance-sheet.row.goodwill-and-intangible-assets

7627.041868.61165.6706.1
622.8
880.5
1103.2
869.4
885.5
772.1
0.6
1.6
2.2

balance-sheet.row.long-term-investments

18.134.94.55.5
17.4
139.4
10
1.5
2.2
44.6
37.2
2.4
0

balance-sheet.row.tax-assets

25.5312.1039.4
32.5
83.7
-79.7
-55.7
-39.3
-14.4
0
-2.4
0

balance-sheet.row.other-non-current-assets

108.8720.932.313
7.3
8.3
6.1
3.3
6
1.6
-0.6
5.8
-6

balance-sheet.row.total-non-current-assets

8211.071996.61339.2895.5
824.1
1269.2
1113.2
869.4
885.5
816.7
37.2
21.7
6

balance-sheet.row.other-assets

0000
0
0
121.1
65.1
49.4
14.4
0
0
2.5

balance-sheet.row.total-assets

10586.212680.31817.31419.5
1370.2
1498
1722.3
1312.7
1199.8
1015.5
38.3
102
16.3

balance-sheet.row.account-payables

227.9948.257.296.1
32.1
37.5
146.8
42.9
43.9
16.7
0
2
2.2

balance-sheet.row.short-term-debt

34.529.77.17.1
33.9
6.3
-122.6
0
0
0
0
10.3
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

2596.52635.1469273.4
325.9
362.5
221
121.4
120.3
0
0
0
0

Deferred Revenue Non Current

763.39583.72.54.4
3.6
1.3
-25.4
-12.3
-35.5
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

330.46---
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

1593.18610.3363.4330.4
321.5
129.2
102
65
67.6
28
0.9
0.7
8.8

balance-sheet.row.total-non-current-liabilities

3982.56938.4524.4280.3
348.8
376.2
386.2
121.4
120.3
21.4
40.3
41.6
0

balance-sheet.row.other-liabilities

343.45000
0
0
0
12.3
35.5
0
-0.9
0
0

balance-sheet.row.capital-lease-obligations

222.0447.763.164.8
69.9
75.1
0
0
0
0
0
0
0

balance-sheet.row.total-liab

6207.461612.6957.9725.8
750.6
569
532.9
266.4
287.7
80.9
40.3
70.9
11.1

balance-sheet.row.preferred-stock

1695.41178.400
0
0
0
0
1199.8
1015.5
0
31
0

balance-sheet.row.common-stock

345.761.210.9
0.9
0.8
0.8
0.8
0.7
0.6
0
0
0

balance-sheet.row.retained-earnings

-2691.57-719.2-606.2-626.8
-589.2
-252
50
86
146.6
306.7
-25.8
0
-20.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-4.76-1.3-1.2-0.4
-0.3
-0.2
-0.2
-14.5
-5.2
-1.2
-4
-1.3
0

balance-sheet.row.other-total-stockholders-equity

5033.921608.61465.71319.9
1208.2
1173.7
1093.2
938.6
-639.4
-672.2
27.7
1.3
25.8

balance-sheet.row.total-stockholders-equity

4378.761067.7859.4693.6
619.6
922.4
1143.8
1010.9
702.5
649.3
-2.1
31
5.2

balance-sheet.row.total-liabilities-and-stockholders-equity

10586.212680.31817.31419.5
1370.2
1498
1722.3
1312.7
1199.8
1015.5
38.3
102
16.3

balance-sheet.row.minority-interest

0000
0
6.7
45.5
35.4
209.6
285.2
0
0
0

balance-sheet.row.total-equity

4378.761067.7859.4693.6
619.6
929
1189.4
1046.3
912.1
934.6
-2.1
31
5.2

balance-sheet.row.total-liabilities-and-total-equity

10586.21---
-
-
-
-
-
-
-
-
-

Total Investments

119.154.9195.5
21.3
141.2
17.1
63.9
46.5
54.1
37.2
2.4
0

balance-sheet.row.total-debt

2626.43644.8476.1280.5
359.8
368.8
221
121.4
120.3
0
0
0
0

balance-sheet.row.net-debt

1949.02452287.914.2
19.3
267.8
-7.3
-117
-14.3
-145.7
0
-67.9
-5.3

现金流量表

在 Evolent Health, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 3.281 的转变。该公司最近通过发行 479.49 扩大了股本，与上一年相比出现了13.695 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-415544000.000. 与上一年相比， 0.604 发生了变化. 在同一时期，公司记录了 123.42, -387.67 和 -464.2，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-18.79 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 300.13，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013

cash-flows.row.net-income

-113.04-113-19.2-37.6
-334.2
-305.6
-54.2
-69.8
-226.8
319.8
-25.2
20

cash-flows.row.depreciation-and-amortization

125.7123.467.260
61.5
60.9
44.5
32.4
17.2
7.2
0
1.2

cash-flows.row.deferred-income-tax

-97.46-31.30.3-0.5
-1.1
-23.1
0
-7.3
-10.8
23.5
0
4.2

cash-flows.row.stock-based-compensation

40.540.53416.7
14.6
15.6
17.6
20.4
22.5
14.7
0
0.1

cash-flows.row.change-in-working-capital

67.7721.9-104.4-13.6
-55.3
0.3
-34.9
-7.3
-4.4
2.2
-49.9
6.2

cash-flows.row.account-receivables

-164.69-164.7-103-5.8
-47
6.3
-24.5
-11.3
-11
11.8
0
-8.7

cash-flows.row.inventory

0-10.70-14.1
47
-19.5
0.6
-1.8
5.1
-5.8
0
2.9

cash-flows.row.account-payables

-6.72-6.713.27.3
3.5
-5.5
7.6
5.6
-6.4
2.8
0
-0.8

cash-flows.row.other-working-capital

232.94204.1-14.6-1
-58.9
19
-18.6
0.2
7.9
-6.6
-49.9
12.8

cash-flows.row.other-non-cash-items

119.11101.110.513.8
298.4
209.2
6.2
3.6
166.7
-387.2
75.1
-45.4

cash-flows.row.net-cash-provided-by-operating-activities

142.58000
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-28.75-28.7-38.4-25
-29.5
-35.5
-39.5
-27.8
-15.5
-6.5
-11
-10.4

cash-flows.row.acquisitions-net

-388.250.95.6-34.8
-0.3
-96.1
-139.6
-4.8
-85.6
13.1
0
-15.5

cash-flows.row.purchases-of-investments

387.45-0.9-5.6-3
-11.2
-11.1
-10
-3.8
0
-54.2
0
0

cash-flows.row.sales-maturities-of-investments

0.870.95.60.5
143.4
2.6
0.3
44.2
9.4
4
0
0

cash-flows.row.other-investing-activites

-387.74-387.7-226.346.5
158.6
-41.5
28.4
-20
-6.1
0
7.5
0.1

cash-flows.row.net-cash-used-for-investing-activites

-415.54-415.5-259.1-15.8
261.1
-181.6
-160.4
-12.3
-97.8
-43.7
-3.6
-25.9

cash-flows.row.debt-repayment

-464.47-464.2-219.7-98.8
-16.6
-62.6
0
0
0
0
0
0

cash-flows.row.common-stock-issued

7.6479.54.513.3
2.6
1.1
0
166.9
177.8
209.1
0
0

cash-flows.row.common-stock-repurchased

-15.29-15.3-18.3-3.9
-1.9
-2.6
0
0
0
0
0
-0.1

cash-flows.row.dividends-paid

-18.79-18.8-14.9-1.3
-20
-61.1
0
0
0
0
0
0

cash-flows.row.other-financing-activites

772.29300.138061.2
24
89.8
274
-1.4
-55.7
0.2
-1.4
34.4

cash-flows.row.net-cash-used-provided-by-financing-activities

281.34281.3131.5-29.5
-11.9
-35.5
274
165.6
122.1
209.2
-1.4
34.3

cash-flows.row.effect-of-forex-changes-on-cash

-0.08-0.1-0.7-0.1
0.1
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

8.38.3-139.8-6.6
233.1
-259.8
93
125.3
-11.2
145.7
-80
-5.3

cash-flows.row.cash-at-end-of-period

847.52223.5215.2354.9
361.6
128.5
388.3
295.4
134.6
145.7
-80
0

cash-flows.row.cash-at-beginning-of-period

839.23215.2354.9361.6
128.5
388.3
295.4
170
145.7
0
0
5.3

cash-flows.row.operating-cash-flow

142.58142.6-11.638.7
-16.2
-42.6
-20.7
-28
-35.5
-19.8
-75.1
-13.6

cash-flows.row.capital-expenditure

-28.75-28.7-38.4-25
-29.5
-35.5
-39.5
-27.8
-15.5
-6.5
-11
-10.4

cash-flows.row.free-cash-flow

113.84113.8-49.913.8
-45.7
-78.2
-60.2
-55.8
-51
-26.3
-86.1
-24.1

利润表行

Evolent Health, Inc. 的收入与上期相比变化了 0.453%。据报告, EVH 的毛利润为 460.47。该公司的营业费用为 481.52，与上年相比变化了 43.113%. 折旧和摊销费用为 123.42，与上一会计期间相比变化了 0.837%. 营业费用报告为 481.52，显示43.113% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长-0.190%. 营业收入为 -71.21，与上年相比变化了0.190%. 净利润的变化率为 5.045%。去年的净收入为-113.04.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

income-statement-row.row.total-revenue

1963.91963.91352908
1022.4
846.4
627.1
434.9
254.2
96.9
0
25.7
8.3

income-statement-row.row.cost-of-revenue

1503.431503.41035.4657.6
701.4
513.1
327.8
269.4
155.2
57.4
0
30
11.3

income-statement-row.row.gross-profit

460.47460.5316.6250.4
321.1
333.3
299.2
165.6
99
39.5
0
-4.3
-2.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

26.7---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

360.23---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

34955.47---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

33.15-62.567.260
61.5
60.9
0.1
0.2
0
7.2
-25.2
0
0

income-statement-row.row.operating-expenses

481.52481.5336.5279.5
372
453.7
350.8
238
177.9
82.5
-25.2
16.8
16.7

income-statement-row.row.cost-and-expenses

1984.9519851371.9937.1
1073.4
966.8
678.6
507.4
333.1
139.8
-25.2
46.8
28

income-statement-row.row.interest-income

5.265.31.40.4
3.2
4
3.4
1.7
0
0
0
0
0

income-statement-row.row.interest-expense

54.254.215.625.4
28.3
14.5
5.5
3.6
0.7
0.3
0
0
0

income-statement-row.row.selling-and-marketing-expenses

34955.47---
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-144.24-132.4-2.2-60
-299.9
-206.7
-0.5
-2
-159.4
386
-25.2
42
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

33.15-62.567.260
61.5
60.9
0.1
0.2
0
7.2
-25.2
0
0

income-statement-row.row.total-operating-expenses

-144.24-132.4-2.2-60
-299.9
-206.7
-0.5
-2
-159.4
386
-25.2
42
0

income-statement-row.row.interest-expense

54.254.215.625.4
28.3
14.5
5.5
3.6
0.7
0.3
0
0
0

income-statement-row.row.depreciation-and-amortization

58.49123.467.260
61.5
54.9
44.5
32.4
17.2
7.2
0
1.2
0.1

income-statement-row.row.ebitda-caps

46.38---
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-62.64-71.2-59.830.2
-37.9
-120.4
-47.5
-72.8
-237.4
-43
-25.2
-21.2
-19.6

income-statement-row.row.income-before-tax

-202.41-202.4-62.1-29.8
-337.8
-327.1
-54.2
-76.4
-237.5
343.3
-25.2
20
-19.6

income-statement-row.row.income-tax-expense

-89.36-89.4-43.40.5
-3.6
-21.5
0
-6.6
-10.8
23.5
0
0
0.3

income-statement-row.row.net-income

-113.04-113-18.7-30.3
-334.2
-305.6
-52.7
-60.7
-159.7
332.5
-25.2
20
-19.3
类似股票
您可能还对以下内容感兴趣：
UTRS
Minerva Surgical, Inc..
0.55 USD
NASDAQ
RCM
R1 RCM Inc..
12.56 USD
NASDAQ
ETAO
ETAO International Co., Ltd..
4.2 USD
NASDAQ
SHCR
Sharecare, Inc..
0.5504 USD
NASDAQ
NARA.CN
Pangenomic Health Inc..
0.08 CAD
CNQ
NRC
National Research Corporation.
39.61 USD
NASDAQ
4172.T
TOWA Hi SYSTEM CO.,LTD..
1770 JPY
JPX
9438.T
MTI Ltd..
734 JPY
JPX
3939.T
Kanamic Network Co.,LTD.
560 JPY
JPX
300288.SZ
Longmaster Information & Technology Co., Ltd..
14.96 CNY
SHZ
CGNSF
Cognetivity Neurosciences Ltd..
0.0127 USD
PNK

常见问题

什么是 Evolent Health, Inc. (EVH) 总资产是多少？

Evolent Health, Inc. (EVH) 总资产为 2680308000.000.

什么是企业年收入？

年收入为 1067070000.000.

企业利润率是多少？

公司利润率为 0.234.

什么是公司自由现金流？

自由现金流为 1.002.

什么是企业净利润率？

净利润率为 -0.058.

企业总收入是多少？

总收入为 -0.032.

什么是 Evolent Health, Inc. (EVH) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 -113040000.000.

公司总债务是多少？

债务总额为 644796000.000.

营业费用是多少？

运营支出为 481525000.000.

公司现金是多少？

企业现金为 192825000.000.